Regarding COVID-19: Canabo Medical Clinic offers virtual and phone appointments. Contact us or call us toll-free at 1-888-282-7763.

FINANCING UPDATE CONCERNING CANABO MEDICAL CORPORATION

FINANCING UPDATE CONCERNING CANABO MEDICAL CORPORATION

Vancouver, British Columbia – Four River Ventures Ltd. (TSXV: FFC.H) (“Four River” or the
“Company”), is pleased to announce that, further to its news release dated September 15, 2016, Canabo
Medical Corporation (“Canabo”), has closed one of the key conditions of the proposed Transaction with
Four River. Canabo has successfully closed a private placement of its common shares at $0.50 per share
to raise gross proceeds of $3,457,500 by issuing 6,915,000 shares. As a result of this strong interest,
Canabo will now be able to rapidly advance its new clinic roll out during the remaining months of 2016
and into 2017.

About Four River Ventures Ltd.
The Company was incorporated in British Columbia on February 2, 2007 and is listed on the NEX
division of the Exchange under the symbol “FFC.H”. The Company’s current business is the exploration
for mineral resources. The Company does not currently have any ongoing operations and has no material
assets other than cash. In accordance with Exchange policy, the Company’s shares are currently halted
from trading and are expected to remain halted until after the Exchange accepts and confirms the
completion of the Transaction. Except for statements of historical fact, all statements in this press release,
including, but not limited to, statements regarding future plans, objectives and payments are forwardlooking
statements that involve various risks and uncertainties.

For more information about Four River, please contact:
Alistair MacLennan
President & Chief Executive Officer
Telephone: (604) 899-0106
Email: Alistair@geocrow.org

For more information about Canabo, please contact
John Philpott
President & Chief Operating Officer
Telephone: (902) 442-0653
Email: johnphilpott@cmclinic.ca

By | 2018-03-07T13:49:30+00:00 September 29th, 2016|News|0 Comments
Newsletter Signup
×